ARTICLE | Finance
Regeneron joins $100M round for DNAnexus to support global growth
June 9, 2020 11:30 PM UTC
Bioinformatics company DNAnexus Inc. raised $100 million in financing to expand its global reach in clinical diagnostic and pharmaceutical markets and medical centers.
Perceptive Advisors and Northpond Ventures LLC led the round, joined by new investor Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and existing investors GV, Foresite Capital Management LLC, TPG Capital and First Round Capital...